Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002079
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin SC-48334 and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4 Cellsmm3 NOTE Asymptomatic HIV-1 Infected Patients Also Eligible
Sponsor:
Organization:
NIH AIDS Clinical Trials Information Service